Cargando…
Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014–2019
SIMPLE SUMMARY: Given ongoing issues with public opinion against the use of animals in biomedical research, scant research resources, high drug costs, low translational success rates, and the length of time that it currently takes for new drugs to reach the market, we undertook a preliminary analysi...
Autores principales: | Marshall, Lindsay J., Triunfol, Marcia, Seidle, Troy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593921/ https://www.ncbi.nlm.nih.gov/pubmed/33092060 http://dx.doi.org/10.3390/ani10101923 |
Ejemplares similares
-
The ripple effects of funding on researchers and output
por: Sattari, Reza, et al.
Publicado: (2022) -
Phase-In to Phase-Out—Targeted, Inclusive Strategies Are Needed to Enable Full Replacement of Animal Use in the European Union
por: Marshall, Lindsay J., et al.
Publicado: (2022) -
Xenograft and organoid model systems in cancer research
por: Bleijs, Margit, et al.
Publicado: (2019) -
High COVID-19 testing rate in Portugal
por: Triunfol, Marcia
Publicado: (2020) -
Global colorectal cancer research, 2007‐2021: Outputs and funding
por: Begum, Mursheda, et al.
Publicado: (2022)